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Heterozygous mutations in proline-rich transmem-
brane protein 2 (PRRT2) underlie a group of parox-
ysmal disorders, including epilepsy, kinesigenic
dyskinesia, and migraine. Most of the mutations
lead to impaired PRRT2 expression, suggesting that
loss of PRRT2 function may contribute to pathogen-
esis. We show that PRRT2 is enriched in presynaptic
terminals and that its silencing decreases the number
of synapses and increases the number of docked
synaptic vesicles at rest. PRRT2-silenced neurons
exhibit a severe impairment of synchronous release,
attributable to a sharp decrease in release probability
and Ca2+ sensitivity and associatedwith amarked in-
crease of the asynchronous/synchronous release ra-
tio. PRRT2 interactswith the synaptic proteinsSNAP-
25 and synaptotagmin 1/2. The results indicate that
PRRT2 is intimately connectedwith the Ca2+-sensing
machinery and that it plays an important role in the
final steps of neurotransmitter release.INTRODUCTION
Over the last 4 years, several studies have identified an array
of heterozygous nonsense, frameshift, and missense mutations
in the gene encoding proline-rich transmembrane protein 2
(PRRT2) in a large number of cases affected by different parox-
ysmal disorders such as benign familial infantile seizures, infan-
tile convulsion choreoathetosis, migraine, hemiplegic migraine,
paroxysmal kinesigenic dyskinesia/choreoathetosis, benign fa-
milial infantile seizures/epilepsy, and episodic ataxia (Chen
et al., 2011; Lee et al., 2012; for review, see Ebrahimi-Fakhari
et al., 2015). The astonishing pleiotropy of the phenotypic
expression of PRRT2 mutations points to an overlap in the path-
ogenic pathways and to a very important role of this gene in regu-
lating synaptic transmission and network activity.
The PRRT2 gene is located in human chromosome 16 and
consists of four exons encoding a poorly characterized proteinThis is an open access article undof 340 amino acids. Most mutations identified in PRRT2 are
phenotypically highly penetrant and cause truncation of the pro-
tein because of nonsense or frameshifts mutations that result in
mRNA degradation by nonsense-mediated mRNA decay or
degradation of the protein (Wu et al., 2014), suggesting a loss-
of-function mechanism of action.
PRRT2 mRNA has been shown to be almost exclusively ex-
pressed in neurons in the cortex, hippocampus, basal ganglia,
and cerebellum (Chen et al., 2011; Lee et al., 2012; Heron
et al., 2012; Trabzuni et al., 2011), which are all regions putatively
involved in the pathogenesis of the PRRT2-linked diseases. The
functional role of this protein is totally unknown. A yeast two-
hybrid screen highlighted a potential interaction of PRRT2 with
synaptosomal-associated protein 25 kDa (SNAP-25), one of
the presynaptic soluble N-ethylmaleimide sensitive factor
(NSF) attachment protein receptor (SNARE) proteins triggering
fusion of synaptic vesicles (SVs) (Stelzl et al., 2005; Lee et al.,
2012). Recently, PRRT2 has also been found among proteins
associated with a-amino-3-hydroxy-5-methyl-4-isoxazolepro-
pionic acid (AMPA)-type glutamate receptors by a high-resolu-
tion proteomics study (Schwenk et al., 2014), and its mutation
was associated with increased levels of extracellular glutamate
(Li et al., 2015).
To investigate the role of PRRT2 in presynaptic physiology,
we silenced PRRT2 expression in primary neurons using RNA
interference. PRRT2 knockdown caused a marked impairment
in synaptic transmission because of a decrease in the density
of synaptic connections and a sharp reduction in release proba-
bility. Both effects were fully reversible upon re-expression of
shRNA-resistant PPRT2. In addition to SNAP-25, the search for
PRRT2 partners identified the fast Ca2+ sensors synaptotagmins
1/2, responsible for triggering synchronous neurotransmitter
release. The results indicate that PRRT2 is intimately connected
with the Ca2+-sensing machinery of neurotransmitter release.
RESULTS
PRRT2 Is a Presynaptic Protein Developmentally
Expressed during Synaptogenesis
We evaluated the regional expression of PRRT2 protein in
various areas of the adult mouse brain and the developmentalCell Reports 15, 117–131, April 5, 2016 ª2016 The Authors 117
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. PRRT2 Is Localized at the Presynaptic Level
(A) Ultrafractionation of brain synaptosomes. Purified synaptosomes from adult mouse brain were subjected to ultrasynaptic fractionation to separate the AZ,
PSD, and NSSP made by extrinsic and integral membrane proteins of the nerve terminal. Aliquots of total synaptosomes and of each ultrasynaptic fraction
(10–30 mg) were probed with antibodies against PRRT2, SNAP-25, and protein markers to validate ultrasynaptic compartments such as synaptophysin-1 (Syp1)
and PSD95 (top). Immunoblots were quantified by densitometric analysis of the fluorograms, and the values are expressed in mean (± SEM) percentages of the
(legend continued on next page)
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expression profile of PRRT2 in both mouse brain and primary
neuronal cultures (Figure S1). PRRT2 expression was prominent
throughout the adult brain, with the highest levels in the cere-
bellum, basal ganglia, and neocortex (Figure S1A). In the cere-
bral cortex and hippocampus, the PRRT2 gene was already ex-
pressed at early postnatal stages, and its expression increased
to reach a plateau at 1 month of life, a period of intense synapse
formation and rearrangement (Figures S1B and S1C). The same
pattern was reproduced in primary hippocampal and cortical
neurons, where PRRT2 expression, already discernible at early
stages, was greatly enhanced between 10 and 21 days in vitro
(DIVs), a temporal window of intense synaptogenesis (Figures
S1B and S1D). In contrast, PRRT2 expression was almost unde-
tectable in primary astroglial cultures (data not shown), consis-
tent with the neuron-specific expression of PRRT2.
To verify the subcellular distribution of PRRT2 at the synapse,
we fractionated purified synaptosomes to isolate synaptic junc-
tions, subsequently separated into active zone (AZ), postsyn-
aptic density (PSD), and a fraction including extrinsic and integral
membrane proteins associated with the presynaptic area (non-
synaptic synaptosomal protein [NSSP]) (Phillips et al., 2001).
PRRT2 was enriched in the NSSP fraction, like SNAP-25 and
synaptophysin. Although the protein appeared to be substan-
tially absent from the PSD, low levels were associated with the
AZ fraction (Figure 1A). We further analyzed PRRT2 enrichment
along a subcellular fractionation procedure, yielding highly puri-
fied SVs (Huttner et al., 1983). Interestingly, we found that
SNAP-25 and PRRT2 had a similar subcellular distribution and
associated with both SVs and presynaptic membrane fractions
(LP2 and FT) (Figure 1B). These data confirm that PRRT2 can
be considered a bona fide presynaptic protein and suggest
that it could undergo trafficking between the presynaptic mem-
brane and the SV compartments, as described previously for
SNAP-25 (Walch-Solimena et al., 1995). The lack of reliable
anti-PRRT2 antibodies for immunocytochemistry did not allow
us to unambiguously visualize the endogenously expressed
protein in tissue and primary neurons. Therefore, to test for the
localization of the protein in neuronal cells, 10-DIVs hippocampal
neurons were transduced with lentiviruses encoding for PRRT2-
mCherry and immunostained at 15 DIVs. In agreement with the
biochemical experiments, PRRT2 colocalized with SNAP-25
and synaptophysin, confirming its targeting to the synapse
(Figure 1C).
To silence PRRT2 expression, five short hairpin RNAs
(shRNAs) were designed on the basis of the open reading frame
of themouse PRRT2 transcript and inserted into lentiviral vectors
expressing either TurboGFP (tGFP) or the mCherry cytosolic re-total amount (bottom). The partition of PSD95, Syp1, and SNAP-25 in the corres
NSSP fraction, similarly to Syp1 and SNAP-25.
(B) Subcellular distribution of endogenous PRRT2 in neurons. Forebrain fractions
using antibodies to PRRT2, SNAP-25, and Syp1 (top). H, homogenate; S1, post-nu
synaptic plasma membranes; LS1, supernatant of LP1; LP2, crude synaptic vesi
highly purified synaptic vesicles; FT, flowthrough fraction containing small presyn
subcellular fraction is expressed in percentage of homogenate as means ± SEM
(C) Localization of PRRT2 in mature neurons. Primary hippocampal neurons trans
at 15 DIVs with antibodies to PRRT2, SNAP-25, and Syp1. PRRT2 immunoreactiv
axonal and nerve terminal areas. Scale bar, 10 mm.
See also Figure S1.porter for cell identification. Four shRNAs were effective in
knocking down PRRT2 expression to very low levels in HeLa
cells, whereas control scrambled shRNAs (Scr) were virtually
ineffective (data not shown). The two most active PRRT2-
shRNAs (Sh1 and Sh4) and two control (Scr) shRNAs were
chosen for the subsequent studies. Because the tested shRNAs
were directed against the PRRT2 coding sequence, we gener-
ated shRNA-resistant PRRT2 clones fused to mCherry for
rescuing the PRRT2 knockdown. Infection of low-density mouse
cortical neurons with the appropriate lentiviral vectors resulted in
an effective silencing of PRRT2 and in the expression of the
shRNA-resistant version of PRRT2 overriding the RNA interfer-
ence (Figures S1E–S1I).
Knockdown of PRRT2 in Low-Density Primary Neurons
Decreases the Density of Synaptic Contacts and Alters
the Synaptic Ultrastructure
Because PRRT2 expression paralleled synapse formation and
rearrangement, we studied whether its knockdown (KD) was
associatedwith changes in synaptic density or assembly. The ef-
fects of PRRT2 KD on synaptic connectivity in primary hippo-
campal neurons were analyzed by counting synapse density in
mature (14 DIVs) neurons infected with either Sh4 or Sh1 at 7
DIVs (Figures 2A and 2B; Figures S2A and S2B). Synaptic bou-
tons were unambiguously identified by counting puncta with a
size of <1 mm double-positive for pairs of pre/postsynaptic pro-
teins such as Bassoon/Homer1 (Figures 2A and 2B; Figure S2A)
or synaptophysin/PSD95 (Figure S2B). Strikingly, the density of
excitatory synapses along dendrites was decreased by z50%
in neurons silenced for PRRT2 with either shRNA, an effect
that was fully rescued by the expression of shRNA-resistant
PRRT2 (Figure 2B; Figure S2B).
Next we ascertained whether the ultrastructure of the rarified
synapses was affected by PRRT2 downregulation (Figures 2C–
2I). Conventional transmission electron microscopy on excit-
atory synapses from primary neurons infected as above con-
firmed the decrease in synapse density in the absence of major
changes in the terminal ultrastructure (Figures 2C and 2D). To
analyze in greater detail the morphology of the PRRT2 KD termi-
nals, we performed serial sectioning followed by 3D reconstruc-
tion (Figure 2E). This analysis detected a 2-fold increase in the
number of docked SVs in PRRT2-silenced synapses in the
context of an unaltered total number of SVs (Figures 2F and
2G). Consistent with this finding, the frequency distribution of
the distance of SVs from the AZ showed an accumulation of
SVs at shorter distances in PRRT2 KD terminals (Figure 2H).
Interestingly, the average diameter of SVs in silenced synapsesponding fractions is shown. Note that PRRT2 preferentially partitioned in the
obtained at various stages of SV purification were analyzed by western blotting
clear supernatant; S2, supernatant of P2; P2, crude synaptosomes; LP1, crude
cles; LS2, synaptosol; USV, highly purified synaptic vesicles; SSV, salt-treated
aptic membranes. Immunoblots were quantified as in (A), and the value of each
(bottom).
duced at 10 DIVs with PRRT2-mCherry (red) were subjected to immunostaining
ity (red) largely overlapped with the staining of the two presynaptic proteins in
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Figure 2. PRRT2 Knockdown Decreases Synapse Density and Increases Docked SVs in Low-Density Hippocampal Neurons
(A) Representative images of dendrites of hippocampal neurons infected at 7 DIVs with Scr, Sh4, and Sh4 + Sh4-resistant PRRT2 (Sh4+PRRT2) or left uninfected
and analyzed at 14 DIVs. Synaptic boutons were identified by double immunostaining for Bassoon (Bsn, red) and Homer1 (green). The colocalization panels (Col.
points) highlight the double-positive puncta (black) corresponding to synapses. Scale bar, 10 mm.
(B) Quantitative analysis of synaptic puncta counted on 30-mmdendrite tracts starting from the cell body in neurons treated as in (A). Data are means ± SEM from
three independent experiments, each carried out in duplicate. Five dendrites for each neuron, from at least ten neurons for each sample, were counted. *p < 0.05,
one-way ANOVA/Bonferroni’s multiple comparison test. NI, not infected.
(C). Conventional TEM analysis of nerve terminals from PRRT2 KD hippocampal neurons revealed an increase in docked SVs and a preservation of the total SVs
with respect to control neurons. Shown are representative TEM images of nerve terminals from neurons transduced with either Scr or Sh4 at 7 DIVs and fixed/
processed at 14 DIVs. Scale bar, 200 mm.
(D) Quantitative TEM analysis of the synaptic density from serial ultrathin sections. The volume density of symmetric and asymmetric synapses was calculated
from the 2D count of synaptic profiles in sections from Sh4- (red bars) and Scr-treated (black bars) neurons and is expressed as mean (± SEM) number of
synapses per square micrometer.
(E). 3D reconstructions of synaptic terminals from serial ultrathin sections confirm the increase in the number of docked SVs in low-density neuronal cultures.
Shown are representative 3D reconstructions from 60-nm-thick serial sections obtained fromScr-treated (left) and PRRT2 KD (right) synapses. Total SVs and SVs
physically docked at the AZ are depicted as blue and red spheres, respectively. The AZ and mitochondria are shown in yellow and green, respectively. Scale bar,
200 nm.
(F and G) Morphometric analysis of three-dimensionally reconstructed synapses. PRRT2 KD synapses (red bars) displayed an increased number of AZ-docked
SVs (F) and a preserved total number of SVs (G) with respect to Scr-treated synapses (black bars).
(legend continued on next page)
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was significantly smaller than the average diameter of SVs in
control terminals (Figure 2I), with an approximate one-third
reduction in SV volume.
We next assessed whether these ultrastructural changes were
altered by neuronal activity. To this aim, we imaged Scr- and
Sh4-infected neurons immediately after a field train stimulation
(300 action potentials [APs] at 10 Hz) and 20 min later (Fig-
ure S2C). Immediately after the stimulation, the density of SVs
was found to be decreased to a similar extent in both Scr- and
Sh4-treated synapses, but, in PRRT2 KD synapses, recovery
was delayed. Interestingly, the increase in the density of docked
SVs observed at rest in PRRT2 KD neurons was not evident
immediately after the stimulation but reappeared after 20 min
of recovery, suggesting a possible role of PRRT2 as a negative
regulator of SV docking at rest.
Knockdown of PRRT2 in Low-Density Primary Neurons
Affects SV Recycling without Modifying the Size of the
Readily Releasable Pool
To couple morphological with functional analysis of SV traf-
ficking and monitor the SV exo-endocytotic cycle at single
synapses, we employed synaptophysin-pHluorin (SypHy), a
pH-sensitive fluorescent sensor exquisitely designed to monitor
the SV exo-endocytosis cycle at single synapses (Figure S3A;
Miesenbo¨ck et al., 1998; Kavalali and Jorgensen, 2014). SypHy
was co-expressed in neurons transduced with either the Scr or
Sh4 variant expressing mCherry as a spectrally non-overlapping
reporter. To evaluate the effect of PRRT2 KD on SV recycling
evoked by electrical activity, field stimulation protocols trig-
gering APswere applied (400 APs at 20 Hz) that allowed us to es-
timate the extent and kinetics of exocytosis and endocytosis
(Verstegen et al., 2014). Experiments were performed at 17
DIVs (5 days after infection), and mCherry/SypHy double-posi-
tive puncta on axonal processes were selected for analysis (Fig-
ure 3A). We found that the SypHy fluorescence increase evoked
by tetanic stimulation was significantly lower in PRRT2-silenced
boutons in the absence of noticeable effects on the kinetics of
‘‘post-stimulus’’ endocytosis (Figures 3B and 3C). When the ki-
netics of release during stimulation were evaluated and fitted ac-
cording to a mono-exponential model, a 2-fold increase in the
time constant was observed in PRRT2-silenced neurons (Fig-
ure 3C). To exclude interference from endocytosis and vesicle
re-acidification, we repeated the analysis in the presence of
the proton pump inhibitor bafilomycin, which allows extracting
the contribution of exocytosis to the rising phase of the fluores-
cence response to stimulation (Figure S3A). Interestingly, the
significant decrease in the fluorescence peak and slowdown of
the release kinetics were virtually abolished, indicating that the
extent and dynamics of exocytosis, as measured by the SypHy(H) Spatial distribution of SVs in nerve terminals of Scr-treated (black symbols) and
within successive 50-nm shells from the AZ and normalized by the total SV conte
the AZ.
(I) Morphometric analysis of SV diameter. PRRT2 KD synapses (red bars) display
Nerve terminal areas (0.689 ± 0.044 mm2 and 0.741 ± 0.035 mm2 for Scr- and PRR
and 0.347 ± 0.013 mm for Scr- and PRRT2 sh-RNA-infected neurons, respectively)
PRRT2 shRNA-infected neurons, respectively, from three independent preparatio
Kolmogorov-Smirnov test (F). See also Figure S2.assay, were notmarkedly altered byPRRT2 silencing (Figure 3C).
This also suggests that PRRT2 silencing may affect during-stim-
ulus endocytosis and/or SV re-acidification.
To clarify whether PRRT2-silenced synapses are impaired in
the priming/fusion steps of release, we stimulated neurons with
40 APs at 20 Hz to measure the readily releasable pool (RRP)
of SVs and assess whether the increased docked SVs observed
by electron microscopy at rest were functional. We found that
both the fluorescence peak at the end of the 2-s stimulation
(representing the RRP size) and the kinetics of fluorescence re-
turn to basal levels at the end of the stimulation (describing the
post-stimulus endocytosis) were virtually unaffected by PRRT2
silencing, indicating that the priming process produces a normal
pool of releasable SVs (Figures 3D and 3E).
To confirm the abovementioned data, we used an alternative,
spectrally distinct reporter of exo-endocytosis, Synaptobre-
vin2-Orange (Syb2O, a pH-sensitive pHluorin based on the
SV protein VAMP2/synaptobrevin; Ramirez et al., 2012) co-ex-
pressed with the green tGFP reporter version of either Sh4-
or Sh1-expressing vectors. The effects of PRRT2 silencing
observed with the SypHy assay were fully reproduced using
the Syb2O reporter and an alternative shRNA to knockdown
PRRT2 (Figure S3B–S3E).
PRRT2 Silencing Reversibly Knocks Down Spontaneous
and Evoked Synaptic Transmission in Autaptic Neurons
To analyze how PRRT2 KD affects the function and strength
of excitatory and inhibitory synapses and avoid the confound-
ing effects of non-transduced neurons, we used autaptic hip-
pocampal neurons. We first checked whether autaptic neu-
rons exhibited the same morphological and ultrastructural
changes observed in low-density cultures. VGLUT1-immuno-
reactive puncta representing autapses were significantly less
numerous in tGFP-positive PRRT2-silenced autaptic neurons,
confirming the results described in low-density cultures (Fig-
ures S4A and S4B). Except for a decrease in total SVs (that
was not apparent in low-density neurons), silenced autaptic
neurons exhibited a phenotype identical to low-density neu-
rons, with a significant increase in the density of SVs docked
at the AZ (Figures S4C and S4D), a shift in the frequency dis-
tribution of the distance of SVs from the AZ with accumulation
of SVs at shorter distances (Figure S4E), and a decrease in SV
diameter (Figure S4F).
Having confirmed the morphological effects of PRRT2
silencing, we proceeded to analyze spontaneous and evoked
synaptic transmission in transduced autaptic neurons identified
based on tGFP/mCherry fluorescence (Figure 4A). Miniature
excitatory postsynaptic currents (mEPSCs) were continuously
recorded at the soma of voltage-clamped neurons held atSh4-treated (red symbols) neurons. The mean (± SEM) number of SVs located
nt of each terminal is given as mean ± SEM as a function of the distance from
ed a smaller SV size with respect to Scr-treated synapses (black bars).
T2 sh-RNA-infected neurons, respectively) and AZ lengths (0.302 ± 0.023 mm
were similar in the two experimental groups (140 and 150 synapses for Scr and
ns). *p < 0.05, **p < 0.01, ***p < 0.001, unpaired Student’s t test (E, G, and H) and
Cell Reports 15, 117–131, April 5, 2016 121
A B
C
D E
Figure 3. PRRT2 Knockdown Slows Down SV Cycling in Response to Sustained High-Frequency Stimulation without Altering Exocytosis
(A). Representative experimental field showing low-density hippocampal neurons co-expressing the reporter of SV exo-endocytosis synaptophysin-pHluorin
(Syphy) and either Sh4 or Scr (mCherry). The merged images show the colocalization of the two markers at synaptic puncta. Scale bar, 10 mm.
(B). Ensemble averaged traces of SypHy fluorescence from PRRT2 KD synapses (Sh4, red trace) and control synapses (Scr, black trace) recorded in response to
electrical field stimulations at 20 Hz for 20 s (shaded area) in the absence or presence of bafilomycin (1 mM). Data are normalized to the maximum fluorescence
intensity reached under NH4Cl perfusion (normalized DF).
(C) Left: quantitative evaluation of the SV pool released during the stimulation and plotted as peak fluorescence reached at the end of the stimulation in the
absence (left) or presence (right) of bafilomycin (Baf). Center: quantitative evaluation of the kinetics of SV endocytosis (t decay phase) by single exponential fitting
of the post-stimulus curves for Sh4-treated (red) and Scr-treated (black) synapses. Right: kinetics of SV release under stimulation at 20 Hz (left) and relative time
constant (t) of the rising phase in the absence or presence of bafilomycin determined by exponential fitting of individual experiments. The rate of SV release was
greatly reduced in PRRT2 KD synapses (Sh4, red trace) comparedwith control synapses (Scr, black trace), but the rate of pure exocytosis determined by blocking
reacidification with bafilomycin was not significantly altered by PRRT2 KD. Data are expressed as mean ± SEM (shown every five time points in B) from 11 (Sh4,
340 synapses) and 13 (Scr, 380 synapses) experiments from three different preparations. **p < 0.01 versus Scr; p < 0.01 versus Sh4+Baf; one-way ANOVA/
Bonferroni’s or Kruskal-Wallis/Dunn’s tests.
(D and E) Evaluation of the readily releasable pool in PRRT2-silenced neurons.
(D) Ensemble-averaged SypHy traces from PRRT2 KD synapses (Sh4, red trace) and control synapses (Scr, black trace) recorded in response to electrical field
stimulations with 40 APs at 20 Hz (shaded area) in the absence or presence of bafilomycin. Fluorescence values were normalized to the maximum fluorescence
intensity reached under NH4Cl perfusion (normalized DF).
(E) Left: peak fluorescence at the end of the stimulus recorded in the absence or presence of bafilomycin. Right: time constant of endocytosis (t decay phase)
evaluated by fitting the fluorescence decay after stimulation by a single exponential function for Sh4-treated (red) and Scr-treated (black) synapses.
Data are expressed as mean ± SEM (shown every five time points in D) from nine (Sh4, 260 synapses) and ten (Scr, 240 synapses) experiments from three
different preparations. See also Figure S3.–70 mV (Vh) in the presence of tetrodotoxin (TTX) to block spon-
taneous APs (Figure 4B; Chiappalone et al., 2009). Strikingly,
the mEPSC frequency fell 3- to 4-fold in PRRT2-silenced cul-122 Cell Reports 15, 117–131, April 5, 2016tures (Figure 4C), an extent much larger than expected from
the decrease in synapse density observed in PRRT2-silenced
autaptic excitatory neurons. Moreover, the mEPSC amplitude,
AB
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Figure 4. PRRT2 Knockdown Dramatically
Decreases Spontaneous and Evoked Syn-
aptic Transmission in Hippocampal Autap-
tic Neurons
(A) Phase-contrast micrographs of a typical hip-
pocampal autaptic neuron (left). The positivity of
the same cell to infection with the Sh4 construct
was probed by fluorescence imaging of the tGFP
reporter (right). Scale bar, 100 mm.
(B) Representative recording traces of mEPSCs
from PRRT2-KD synapses (Sh4, red traces) and
control synapses (Scr, black trace).
(C) Analysis of mEPSCs. From left to right, shown
are mean ± SEM frequency, amplitude, charge,
80% decay time, and 10%–90% rise time of
mEPSCs calculated for PRRT2 KD (n = 11, red
bars) and control (n = 15, black bars) neurons. All
values were obtained from 100–1000 events
recorded from each cell in 5-min recordings.
(D) Representative eEPSCs recorded in excitatory
autaptic neurons infected with Scr (black trace/
bar, n = 39), PRRT2-Sh4 (red trace/bar, n = 32), or
PRRT2-Sh4 + Sh-resistant PRRT2 (gray trace/bar,
n = 21). eEPSCs were elicited by clamping the cell
under study at –70 mV and stimulating it with two
voltage steps to +40 mV lasting 0.5 ms at an inter-
stimulus interval of 50 ms. The paired-pulse stim-
ulation was applied every 10 s (inset).
(E) Decrease of eEPSC amplitude and increase of
PPR by PRRT2 KD and rescue of the PRRT2 KD
phenotype by expression of Sh-resistant PRRT2.
Shown is the quantitative analysis of the eEPSC
amplitude evoked by the first pulse (I1, left) and
PPR (I2/I1, right) recorded in excitatory autaptic
neurons treated as described in (D). A complete
rescue of the EPSC amplitude and PPR was
observed in silenced neurons expressing Sh-
resistant PRRT2.
In all graphed currents, stimulation artifacts
were blanked for clarity. Data are expressed as
means ± SEM from the indicated numbers of cells
recorded from at least three independent cell
culture preparations. *p < 0.05, **p < 0.01, ***p <
0.001, unpaired Student’s t test or Mann-Whit-
ney’s U test (C); Kruskal-Wallis/Dunn’s multiple
comparison test (E). See also Figures S4 and S5.reflecting quantal size, was also decreased by approximately
30% in the absence of significant changes in the current wave-
form, as indicated by the analysis of decay and rise times (Fig-
ure 4C). A reduction of approximately the same extent was
also observed in the mEPSC area (unitary charge). Such a
change may be attributable to the corresponding reduction in
the average SV volume, although concomitant postsynaptic ef-
fects cannot be excluded.
For the analysis of evoked transmission, transduced autap-
tic neurons, identified as excitatory or inhibitory based on the
kinetics of postsynaptic currents (PSCs) and sensitivity to
specific blockers of AMPA or g-aminobutyric acid receptor
type A (GABAA) receptors, were stimulated with paired stimuli
at an interpulse interval of 50 ms to evaluate the paired-pulse
ratio (PPR), an indirect measure of release probability (Fiora-
vante and Regehr, 2011). Strikingly, the vast majority of excit-atory neurons knocked down for PRRT2 by either Sh4 or Sh1
and analyzed over time in culture displayed a dramatic
decrease of EPSC amplitude in response to single stimuli
with a strong increase in paired-pulse facilitation (Figures 4D
and 4E; Figures S5A–S5D), suggesting a presynaptic defect
affecting release probability. The effect of PRRT2 silencing
was reversible; co-infection of the neurons with Sh-resistant
PRRT2 was able to achieve a virtually complete return of cur-
rent amplitude and PPR to the levels of Scr-infected neurons
(Figures 4D and 4E). The magnitude of the synaptic impair-
ment increased with development, suggesting an absent or
delayed maturation of the release machinery in PRRT2-
silenced neurons (Figure S5B).
A closely similar phenotype was observed in PRRT2-silenced
inhibitory neurons, which represent 7%–10% of the total autap-
tic neuronal population under our culture conditions (Figure S5E).Cell Reports 15, 117–131, April 5, 2016 123
Figure 5. PRRT2 Knockdown Strongly De-
creases Synchronous but Not Asynchro-
nous Release in Excitatory Autapses
(A) Representative recordings of eEPSCs evoked
by high-frequency stimulation (train of 80 stimuli
at 40 Hz, inset) in autaptic hippocampal neurons
infected with Scr (black trace) or PRRT2-Sh4
(red trace). Stimulation artifacts were blanked for
clarity.
(B) Profiles of the mean cumulative amplitude of
eEPSCs for neurons infected with Scr (black trace,
n = 38) or PRRT2-Sh4 (red trace, n = 34) con-
structs. Data points in the 1- to 2-s range were
fitted by a linear regression and back-extrapolated
to time 0 (solid lines) to estimate the RRPsyn.
(C) Results of the quantal analysis. From left to
right, shown are the mean ± SEM amplitude of the
first eEPSC, RRPsyn size, number of RRPsyn
quanta, and initial probability of release (Pr) esti-
mated in neurons infected with Scr (n = 38, black
bars) or PRRT2-Sh4 (n = 34, red bars).
(D) Representative traces showing asynchronous
release evoked by a tetanic stimulation of 2 s at
40 Hz in autaptic neurons transduced with either
Scr (black traces) or PRRT2-Sh4 (red traces).
Traces in the insets are shown in an expanded
timescale.
(E–G) Comparative analysis of synchronous and
asynchronous release.
(E) Individual values and mean (± SEM) of the
synchronous charge released from Scr-infected
(black, n = 26) and Sh4-infected (red, n = 26)
neurons stimulated by one AP 10 s before the
train. Synchronous charge was estimated by
measuring the area of the eEPSC in a time window
of 5 ms following its activation.
(F) Time course of asynchronous release calcu-
lated by measuring the area of the spontaneous
EPSCs evoked by tetanic stimulation. The area
was calculated in nine time windows, each last-
ing 1 s.
(G) Time course of the synchronous/asynchronous
ratio calculated for the nine time windows from the
data shown in (C) and (B), respectively.
(H and I) Estimation of RRPtotal by hypertonic
stimulation of autaptic neurons.
(H) Representative EPSC responses activated by
6 s of hypertonic stimulation (horizontal bar) re-
corded in autaptic neurons transduced with either
scrambled shRNA (black) or PRRT2-Sh4 (red).
(I) Mean values (± SEM) of the RRPtotal charge transfer obtained by hypertonic stimulation and number of RRPtotal quanta obtained in either Scr (black, n = 18) or
PRRT2-Sh4 (red, n = 15) neurons by dividing the RRPtotal charge by the unitary mEPSC charge.
Data are shown as means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, unpaired Student’s t test or Mann-Whitney U test.The impairment of the evoked inhibitory current appeared to be
even more dramatic than that of excitatory neurons recorded in
the same plates (inset in Figure S5F). In analogy to what was
observed for excitatory transmission, the strong impairment in
inhibitory transmission was associated with an increase in
PPR, which made paired-pulse depression milder (Figure S5G).
The results suggest that PRRT2 downregulation affects the Ca2+
coupling between action potential and exocytosis by decreasing
the probability of release (Pr), thereby rendering facilitation more
intense in excitatory synapses or depression milder in inhibitory
synapses.124 Cell Reports 15, 117–131, April 5, 2016PRRT2 Knockdown Decreases the Probability of
Synchronous Release and Greatly Increases the
Asynchronous/Synchronous Release Ratio
To identify the quantal parameters of release affected by PRRT2
silencing, we performed cumulative evoked EPSC (eEPSC)
amplitude analysis in control and silenced autaptic excitatory
neurons. When neurons were challenged with a train of 2 s at
40 Hz, a significant depression of eEPSCs became apparent
during the train in both control and silenced neurons, irrespective
of the amplitude of the first current in the train (Figure 5A).
Accordingly, the cumulative profile showed a rapid rise followed
by a slower linear increase, reflecting the equilibrium between
the depletion and constant replenishment of the RRP (Figure 5B).
Interestingly, the 4- to 5-fold reduction of the current ampli-
tude in silenced neurons was contributed by a sharp (about
65%) decrease in the initial Pr together with a significant
decrease of the RRPsyn total current. However, when the readily
releasable pool current of synchronous release (RRPsyn) was
normalized by the unitary current (Qav, corresponding to the
average amplitude of autaptic mEPSCs), the number of readily
releasable SVs (Nsyn) was not significantly different between
control and PRRT2-silenced neurons (Figure 5C), suggesting,
in agreement with the results of the SypHy assay, a normal prim-
ing process generating the RRP in PRRT2 KD neurons. There-
fore, the strong impairment in evoked synchronous release is
likely to involve changes in the Ca2+ dependence of release
that can occur at the level of either Ca2+ entry or Ca2+ sensing.
Because asynchronous release has a distinct Ca2+ sensitivity,
we measured both the synchronous and the delayed asynchro-
nous release as the transferred charge in response to trains of 2 s
at 40Hz (Medrihan et al., 2013; Figure 5D). Although the synchro-
nous charge, measured as the response to a single AP 10 s
before the train, was dramatically decreased in PRRT2-silenced
neurons (Figure 5E), both control and silenced autapses showed
a robust asynchronous release after the train that slowly returned
to baseline within 10 s (Figures 5F and 5G). In PRRT2-silenced
autapses, asynchronous release was significantly decreased
only immediately after the end of the train, but thereafter it was
indistinguishable from that of control autapses (Figure 5F).
When the asynchronous/synchronous charge ratio was calcu-
lated (Figure 5G), silenced neurons had a percent asynchronous
versus synchronous release that was much larger than that of
control neurons. This is compatible with the normal released
SV pool observed with the SypHy assay (as shown previously
shown for Syt1 knockout neurons; Nishiki and Augustine,
2004) and further suggests that the main impairment in the
absence of PRRT2 resides in Ca2+ sensing commanding fast,
synchronous release and not in the subsequent asynchronous
SV fusion process.
Given the sharp decrease in synchronous release and the sub-
stantial preservation of asynchronous release, we assessed the
RRP size of the total release (RRPtotal) with a fully independent
procedure; i.e., by exposing synapses to hypertonic sucrose
stimulation (Figure 5H). Consistent with the data reported above,
during the transient part of the high sucrose-induced eEPSC, a
significant decrease of the charge transfer, a reliable measure
of RRPtotal, was observed in PRRT2-silenced neurons (Figure 5I).
However, when RRPtotal was normalized by the unitary SV
charge, the resulting quantal content of RRPtotal was comparable
between control and PRRT2-silenced neurons (Figure 5I). The
substantial preservation of the total pool of readily releasable
SVs indicates that the same total SV pool is shared by synchro-
nous and asynchronous release and further suggests that SV
priming is not affected by PRRT2 silencing.
PRRT2 Knockdown Decreases the Ca2+ Sensitivity of
Synchronous Release and Alters Short-Term Plasticity
Given the sharp impairment in spontaneous and evoked release,
we investigated the Ca2+ sensitivity of release by increasing theextracellular Ca2+ concentration or by challenging synchronous
and asynchronous release with the cell-permeable Ca2+ chelator
EGTA-acetoxymethyl (EGTA-AM). In Scr-treated neurons, the in-
crease in external Ca2+ from 2 to 4 mM enhanced the frequency
and amplitude of mEPSCs (Figure 6A) as well as the amplitude of
eEPSCs while decreasing PPR (Figure 6B), consistent with a
heightened release probability. Strikingly, PRRT2-silenced neu-
rons were totally insensitive to the increase in extracellular
Ca2+ as far as both spontaneous and evoked release were
concerned.
Known as a slow chelator, EGTA should be more active in in-
hibiting delayed asynchronous release rather than fast, synchro-
nous release triggered by Ca2+ increases in the nanodomains
adjacent to Ca2+ channels. However, in control hippocampal
autapses, EGTA-AM application significantly reduced both syn-
chronous and asynchronous release to approximately the same
extent, indicating that fast release occurs within microdomains
generated by the spatial overlap of local Ca2+ influxes through
multiple adjacent Ca2+ channels (Wang and Augustine, 2014).
Interestingly, the effect of EGTA was fully occluded by PRRT2
KD, consistent with an effect on the Ca2+ dependency of release
(Figure 6C).
An alternative way to assess Ca2+ sensitivity of release is to
investigate facilitation and potentiation, which are short-term
plasticity phenomena depending on an activity-dependent
Ca2+ build-up in the nerve terminal (Figure S6; Fioravante and
Regehr, 2011). Excitatory autaptic neurons were stimulated
with 2-s trains at frequencies ranging from 10–40 Hz, and the
development of facilitation/depression was analyzed over time.
PRRT2-silenced neurons were characterized by a massive and
intense facilitation whose peak was significantly delayed with
respect to that of control neurons (Figures S6A and S6C). Inter-
estingly, the amplitude of the last EPSC of the train became
indistinguishable from the last EPSC of control neurons that
was largely depressed at 40 Hz of stimulation (Figure S6B).
When the EPSC amplitude during the train was normalized
with the amplitude of the first EPSC, PRRT2-silenced neurons
exhibited an intense and prolonged facilitation without experi-
encing any depression during 10- or 20-Hz trains (Figure S6C).
Although the pronounced facilitation and the increased PPR
are the likely consequences of the low initial Pr, the delay in
the facilitation peak further suggests an impaired Ca2+-sensing
ability. Post-tetanic potentiation (PTP) is a form of short-term
synaptic plasticity contributed by increases in both RRP and Pr
induced by the train stimulation (Fioravante and Regehr, 2011;
Valente et al., 2012). A short high-frequency stimulation (HFS)
(2 s at 40 Hz; Figure S6D) was used to evoke PTP, and a single
stimulus applied every 10 s was used to monitor the plastic
changes in eEPSC amplitude. PRRT2-silenced neurons ex-
pressed an approximately 30% smaller potentiation than Scr-
treated control neurons (Figures S6E and S6F), consistent with
an inability of PRRT2-silenced neurons to increase the Pr
because of an impairment in the Ca2+ sensing process.
PRRT2 Interacts with SNARE Proteins and
Synaptotagmins 1 and 2
The physiological phenotype of PRRT2 silencing prompted the
search for possible presynaptic PRRT2 interactors implicated inCell Reports 15, 117–131, April 5, 2016 125
AB
C
Figure 6. The Ca2+ Sensitivity of Spontaneous and Synchronous
Release Is Decreased by PRRT2 Knockdown
(A) Amplitude (left) and frequency (right) of mEPSCs recorded in neurons
transduced with Scr (black/gray bars, n = 9/7) and Sh4 (red/orange bars, n =
10/8) as a function of the extracellular Ca2+ concentration (2 mM Ca2+, black/
red bars; 4 mM Ca2+, gray/orange bars).
(B) eEPSC amplitude evoked by the first pulse (I1, left) and PPR (I2/I1, right)
recorded in neurons transduced with Scr (black/gray bars, n = 7) or PRRT2-
Sh4 (red/orange bars, n = 6). The graph bars represent the mean of the EPSC
amplitude and PPR recorded in individual cells before (black/red bars) and
after (gray/orange bars) the increase of the extracellular Ca2+ concentration to
4 mM.
(C) Effects of EGTA-AM on synchronous and asynchronous release. Left:
synchronous charge released from Scr-treated (black/gray bars, n = 12) and
Sh4-treated (red/orange bars, n = 11) neurons stimulated by one AP 10 s
before the train. Synchronous charge was estimated by measuring the area of
the eEPSC in a time window of 5 ms following its activation. Center: asyn-
chronous charge induced by a tetanic stimulation of 2 s at 40 Hz and calcu-
lated by measuring the area of the spontaneous EPSCs in the time window of
1 s after the end of the train. Right: synchronous/asynchronous ratio calculated
for the nine time windows from the data shown in (C) and (B), respectively.
Data are means ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001, one-way ANOVA/
Bonferroni’s multiple comparison test. See also Figure S6.
126 Cell Reports 15, 117–131, April 5, 2016the post-docking events of release. We focused on presynaptic
proteins that, when inactivated in knockout (KO) mice, cause a
strong impairment in evoked release, including the SNARE pro-
teins VAMP2, SNAP-25, and syntaxin 1, the fast Ca2+ sensors
synaptotagmins (Syt) 1/2, Rab3 interactingmolecule (RIM) bind-
ing protein, complexins 1/2, and Munc-18 (S€udhof, 2013).
FLAG-tagged PRRT2 or a FLAG-tagged control purified in eu-
karyotic cells was used to pull down PRRT2 interactors from
synaptosomal extracts of the mouse brain. A significant pull-
down of Syt2 as well as a somewhat weaker interaction with
SNAP-25 and its SNARE partner VAMP2 were observed in the
absence of significant interactions with the other proteins tested
(Figure 7A). Although the interaction of PRRT2 with SNAP-25
has been reported previously (Stelzl et al., 2005; Lee et al.,
2012; Li et al., 2015), the interaction with Syt2, a fast Ca2+
sensor highly homologous to Syt1 (S€udhof, 2013), is of great in-
terest in light of the physiological phenotype associated with
PRRT2 silencing. Under our conditions, Syt2 was expressed
by both low-density and autaptic hippocampal neurons,
although to a much lesser extent and with a more restricted
pattern than the major isoform Syt1 (Figure S7A), consistent
with previous reports (Pang et al., 2006a; Fox and Sanes,
2007; Kerr et al., 2008).
In view of the high homology of Syt2 with Syt1, and to
explain the wide-range synaptic phenotype of PRRT2 knock-
down, we further considered the possibility of an interaction
of PRRT2 with Syt1 that might have escaped the conven-
tional pull-down assay. Co-immunoprecipitation experiments
from brain extracts with anti-Syt1 and anti-Syt2 antibodies
showed that PRRT2 indeed associates with both Syt1 and
Syt2 (Figure 7B). Because the lack of an interactor may
affect the lifetime of its partner, we investigated whether the
levels of Syt1 and/or Syt2 in low-density hippocampal cultures
were affected by PRRT2 silencing. Both Syt isoforms were
decreased in PRRT2 KD neurons. However, although the
levels of Syt2 were decreased to the same extent as those
of other synaptic proteins, likely expressing the decrease in
synapse density, Syt1 expression levels were significantly
smaller (Figure S7B).
In support of the hypothesis that the wide-range synaptic
phenotype of PRRT2 KD is attributable to the interaction with
either or both Syt1/Syt2, we tried to rescue the impairment in
the evoked synchronous release by overexpressing Syt2 in
PRRT2 KD autaptic neurons (Figure S7C). Expression of Syt2
induced a significant rescue of PRRT2 KD-induced impairment
in eEPSC amplitude, although its magnitude was smaller
than the complete rescue obtained with Sh-resistant PRRT2
(Figure 7C).
DISCUSSION
The dominant effect of PRRT2 mutations associated with
diverse paroxysmal disorders points to an important role of
the protein in neuronal activity. Because most of the mutations
display a loss-of-function pathogenic mechanism of action, we
used an acute silencing approach through RNA interference to
dissect out the physiological role of the protein at the synaptic
level.
Presynaptic Actions of PRRT2
Putative interactions with the SNARE protein SNAP-25 and the
GluA1 subunit of the AMPA-type glutamate receptor complex
have been suggested on the basis of proteomic studies (Stelzl
et al., 2005; Schwenk et al., 2014). These interactions were sub-
sequently demonstrated using recombinant PRRT2 (Lee et al.,
2012; Li et al., 2015), opening the question of whether PRRT2
acts at the presynaptic level, postsynaptic level, or both. In this
work, we provide evidence for a strong involvement of PRRT2
in presynaptic function. PRRT2 is increasingly expressed during
synaptogenesis and, in mature synapses, codistributes with pre-
synaptic markers such as synaptophysin or SNAP-25. Consis-
tently, PRRT2 silencing in primary neurons decreases the den-
sity of synaptic connections and alters the nerve terminal
ultrastructure. Stronger evidence for a presynaptic action comes
from the effects of PRRT2 silencing on synaptic transmission.
Indeed, in the absence of PRRT2, a downregulation of neuro-
transmitter release occurs with a dramatic impairment in sponta-
neous and synchronous release. The major traits of the PRRT2
KD phenotype (namely, the decreased frequency of mEPSCs,
the impairment of evoked currents in both excitatory and inhibi-
tory synapses, the increase in PPR, the selective drop in the
initial Pr, the changes in short-term plasticity responses such
as facilitation, depression, or PTP that are expressed predomi-
nantly at presynaptic level, as well as the ultrastructural changes
testifying to an accumulation of SVs in the proximity of the
release sites at rest) all strongly indicate that PRRT2 is an impor-
tant presynaptic component of the release machinery. SypHy
imaging experiments also uncovered an additional effect of
PRRT2 silencing on SV recycling and/or acidification that con-
firms the presynaptic site of action of PRRT2.
PRRT2 and Synapse Morphology
One major effect of acute PRRT2 silencing is a decrease in the
density of synaptic connections. The decreased number of syn-
aptic contacts is more likely attributable to a developmental ef-
fect of PRRT2 whose expression parallels the period of synaptic
formation and remodeling, although plastic pruning of downre-
gulated synapses cannot be ruled out. The decreased density
of synaptic connections was not accompanied by dramatic
changes in the synaptic ultrastructure, except for an increase
in the density of docked SVs at rest that is relieved by activity,
suggesting that PRRT2 negatively controls SV docking under
resting conditions, and a smaller SV volume that parallels the
decrease in quantum size observed in the analysis of miniature
synaptic currents. Because a pool of PRRT2 is associated with
SVs, it is tempting to speculate that it may participate in the con-
trol of the integrity, size, and curvature of these organelles.
Further studies are needed to dissect themolecular mechanisms
of this effect.
PRRT2 and the Quantal Properties of Release
Quantal analysis has shown that the quantum size is decreased,
the RRP of SVs is preserved, and the probability of spontaneous
and evoked release is severely decreased in the absence of
PRRT2. Although the decrease in quantum size is of the same
magnitude as the reduction in SV volume, several considerations
point to a fundamental role of PRRT2 in the machinery for syn-chronous release; namely, the decrease in the frequency of
spontaneous release was much larger than the decrease in syn-
apse density, the probability of evoked release was dramatically
decreased, and modifications of nerve terminal Ca2+ levels re-
vealed a defective Ca2+ secretion coupling.
These results suggest that a defect in the progression of SVs
through the post-docking steps of release exists in PRRT2-
silenced synapses. Three independent evaluations prove that
the RRP size is preserved and that priming is not markedly
altered. The effects on Pr and on the efficiency of Ca2+-depen-
dent fusion would suggest that the defect of PRRT2 silencing re-
sides in the Ca2+-sensing apparatus and/or in the fusionmachin-
ery. However, the persistence of asynchronous release indicates
that the fusion mechanism per se is not disabled in the absence
of PRRT2 and that an acute defect in coupling the fast Ca2+ influx
to exocytosis is likely to be involved.
PRRT2: Component of the Fusion Machinery or
Ca2+-Sensing Device?
To test for known interactors of PRRT2, we screened an array of
major presynaptic proteinswhose constitutive knockout strongly
impairs evoked transmission (see S€udhof, 2013, for a review).
Besides confirming the interaction with SNAP-25, we found
that PRRT2 also associates with VAMP2 and Syt1/2.
The interactions with the SNARE proteins SNAP-25 and
VAMP2would suggest that PRRT2 acts as a catalyst in the hemi-
fusion/fusion processes, although the relative preservation of
asynchronous release argues against a major impairment in
SNARE function and fusion. On the other hand, the dramatic
drop in evoked synchronous release, which was insensitive to
manipulations of the intraterminal Ca2+ levels, and the delayed
peak of facilitation point to a defective excitation-secretion
coupling in which either Ca2+ entry or Ca2+ sensing could be
affected.
The interactions with Syt1/Syt2 open the possibility that
PRRT2 participates in the regulation of the Ca2+-sensing appa-
ratus for fast synchronous release. Such interactions may
involve the large N-terminal region of PRRT2 that we have shown
recently to have an intracellular topology (Rossi et al., 2016).
Together with Syt9, Syt1 and Syt2 are the synaptotagmins that
mediate fast Ca2+-triggered SV exocytosis (Xu et al., 2007;
Pang and S€udhof, 2010; Kochubey et al., 2011). Syt1 and Syt2
are highly homologous, form hetero-oligomers on the SV mem-
brane (Osborne et al., 1999), and are thought to act in much
the same way. Knockout of either Syt abolishes Ca2+-triggered
synchronous release, and the two Syts appear to be inter-
changeable to some extent in rescuing their knockout phenotype
(Xu et al., 2007; Nagy et al., 2006).
Deletion of Syt1 in neurons revealed that the protein is essen-
tial for mediating fast and synchronous fusion events in response
to isolated APs but is not required for spontaneous fusion (that is
enhanced) and slow asynchronous fusion (Geppert et al., 1994).
At the mouse neuromuscular junction, where Syt1 and Syt2 are
co-expressed, genetic deletion of Syt2 generates a strikingly
similar phenotype to PRRT2 silencing with a dramatic reduction
and slowdown of evoked release, decreased release probability,
marked increase in facilitation, and asynchronous release during
and after stimulus trains (Pang et al., 2006a). In the calyx of Held,Cell Reports 15, 117–131, April 5, 2016 127
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Figure 7. PRRT2 Interacts with the SNARE Complex Proteins and the Fast Ca2+ Sensors Synaptotagmin 1 and 2
(A) Pull-down assays with FLAG-tagged PRRT2. Left: FLAG-tagged PRRT2 (PRRT2) and bacterial alkaline phosphatase (BAP) vectors were expressed in
HEK293T cells, purified by anti-FLAG M2 affinity gel, and incubated with synaptosome lysates. After pull-down (PD), pellets were solubilized and subjected to a
western blotting assay together with aliquots of the starting material (input) and of the supernatants (SUP) using antibodies for a variety of potential presynaptic
interactors of PRRT2, as shown. Vertical white lines in the blot indicate that the lanes were on the same gel but have been repositioned in the figure. Synaptosomal
lysates incubated with FLAG-PRRT2 showed specific immunoreactivity for the SNARE complex proteins SNAP-25 and VAMP2 and for Syt2, which was not
detected in FLAG-BAP precipitates. RIMBP, Rim binding protein; Syt, synaptotagmin; Stx-1A, syntaxin-1A, CPLX, complexins 1/2. Right: Immunoblots were
quantified by densitometric analysis of the fluorograms obtained in the linear range of the emulsion response. The percent increase in the specific pull-down of the
immunoreactivity (IR) by FLAG-PRRT2 with respect to the non-specific IR pulled down by the FLAG-BAP control ((IRPRRT2 – IRBAP) / IRBAP) was calculated and is
shown for each potential interactor as mean ± SEM (n = 3–4 independent PRRT2 preparations and subcellular fractionations).
(B) Co-immunoprecipitation of PRRT2 with Syt1 and Syt2. Detergent extracts of mouse brain were immunoprecipitated (IP) with monoclonal antibodies (mAbs)
specific for Syt1 and Syt2 or with the respective control mouse immunoglobulin Gs (IgGs) as indicated. After electrophoretic separation of the immunocomplexes
and western blotting, membranes were probed with anti-Syt1/anti-Syt2 antibodies to test the efficiency of the immunoprecipitation as well as with polyclonal
(legend continued on next page)
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where Syt2 is the only fast Ca2+ sensor to be expressed, Syt2 KO
deletes fast release but leaves asynchronous release unaffected
(Sun et al., 2007). A similar dramatic reduction and slowdown of
evoked release was present in a mouse strain bearing a destabi-
lizing Syt2 mutation (Pang et al., 2006b) and exhibiting ataxia,
one of the manifestations of PRRT2 mutations in patients.
Because it is known that spontaneous, synchronous, and
asynchronous release modalities rely on distinct ranges of
Ca2+ concentrations and, potentially, on distinct Ca2+ sensors,
it is tempting to speculate that the interaction of PRRT2 with
Syt1/2 is the key to mechanistically explain the strong and selec-
tive impairment of synchronous release with PRRT2 KD. The
main phenotypic difference between Syt KOs and PRRT2 KD
is observed in spontaneous release, which is increased in the
former and impaired in the latter because of the concomitant
decrease in synapse density. Our data suggest amodel whereby
PRRT2, by binding to SNAP-25 and Syt1/2, would increase the
affinity of the SNARE complex for the fast Ca2+ sensor so that,
in the absence of PRRT2, less SNARE complexes bind to the
sensor, resulting in a dramatic decrease of the release probabil-
ity. According to this model, the interactions between PRRT2
and Syt1/2 would be necessary to boost the Ca2+ sensitivity of
evoked fast release, whereas they would be dispensable for
the Syt-mediated clamping action on spontaneous release.
Finally, the similar PRRT2-silencing phenotype found in excit-
atory and inhibitory autapses is fully consistent with an interac-
tion of PRRT2 with both Syt1 and Syt2, which appear to be partly
segregated in excitatory and inhibitory neurons, respectively
(Fox and Sanes, 2007; Kerr et al., 2008; Pang et al., 2006a).
In conclusion, we demonstrate here that PRRT2 is an impor-
tant regulator of the Ca2+-sensing and SV fusion machinery.
The results are consistent with amodel in which PRRT2, by inter-
acting with the fast Ca2+ sensors Syt1/2 and SNAREs, endows
the SNARE complex with Ca2+ sensitivity. Further investigations
will be needed to clarify the physiological regulation of these in-
teractions and how their perturbation leads to brain paroxysmal
activity.
EXPERIMENTAL PROCEDURES
Sprague-Dawley rats and C57BL/6Jmice of either sex fromCharles River Lab-
oratories were used throughout. All experiments were carried out in accor-
dance with the guidelines established by the European Communities Council
(Directive 2010/63/EU of March 4, 2014) and were approved by the Italian Min-
istry of Health. The standard procedures for subcellular fractionation, western
blotting, immunocytochemistry, pull-down and co-immunoprecipitation as-
says, real-time PCR, and cultures of low-density and autaptic hippocampal
neurons are reported in detail in the Supplemental Experimental Procedures.
Transduction of Primary Neurons with PRRT2 shRNA and/or
Sh-Resistant PRRT2
shRNAs (Scr, Sh1, and Sh4; Supplemental Experimental Procedures) were in-
serted into the pLKO.1-CMV-TurboGFP or pLKO.1-CMV-mCherry plasmid ex-anti-PRRT2 antibodies. Left: a representative immunoblot is shown. Right: qu
samples, normalized to the binding to the mouse IgG control (means ± SEM, n =
(C) Overexpression of Syt2 partially rescues the impairment in synchronous releas
with Scr (n = 31), Sh4/mCherry (Sh4, n = 30), Syt2/GFP (Syt2, n = 28), or Sh4+Syt2
eEPSC amplitude evoked by the first pulse (I1, left) and of the PPR (I2/I1, right). *p
(I1); one-way ANOVA/Bonferroni’s multiple comparison test (PPR). See also Figupressing either free tGFP or mCherry for the identification of the transfected
cells. The PRRT2 Sh-resistant isoforms were subcloned into lentiviral vectors
743.pCCLsin.PPT.hPGK.GFP.Wpre (a gift from Dr. L. Naldini). Lentiviral vec-
tors encoding Sh1, Sh4, or the Scr control RNAs were used to knock down
the endogenous PPRT2 protein in hippocampal neurons. Neurons were in-
fected by the addition of lentiviral vectors into cell medium at 6 DIVs. After
24 hr, the medium was removed and replaced with fresh and conditioned me-
dium (1:1). A multiplicity of infection (MOI) of 5 of the lentivirus was used. For
rescue experiments, neurons were co-transduced with lentiviruses expressing
Sh1 or Sh4 shRNA and lentiviruses expressing the Sh1- or Sh4-resistant
PRRT2-Cherry (5 MOI + 5MOI) or with Scr sh-RNA (10 MOI). Syt2 overexpres-
sion was performed by co-infection of autaptic neurons with the Sh4 shRNA
vector expressing soluble mCherry and with a lentiviral vector expressing
Syt2 and soluble GFP (Biomatik). All physiological experiments were conduct-
ed between 10 and 15 DIVs.
Live Imaging of Exo-endocytosis
To couple the synaptic ultrastructure with functional analysis of SV trafficking,
we employed Syphy and Syb2O, fluorescent probes exquisitely designed to
monitor the SV exo-endocytosis cycle at single synapses (Figure S3A;Miesen-
bo¨ck et al., 1998; Ramirez et al., 2012). Optical recordings were performed at
17 DIV (5 days after transduction), as described in detail in the Supplemental
Experimental Procedures.
Transmission Electron Microscopy
Autaptic hippocampal neurons and low-density cultures of hippocampal neu-
ronswere infected at 7–11DIVswith either scramble shRNA or PRRT2 shRNAs
and processed for transmission electron microscopy (TEM). The detailed pro-
cedures are reported in the Supplemental Experimental Procedures.
Patch-Clamp Recordings
Whole-cell patch-clamp recordings were made from autaptic neurons
grown on microislands, as described previously (Valente et al., 2012). The
detailed procedures are reported in the Supplemental Experimental
Procedures.
Statistical Analysis
Data were expressed as means ± SEM for number of cells (n). Normal distribu-
tion was assessed using D’Agostino-Pearson’s normality test. To compare
two sample groups, Student’s t test or Mann-Whitney U test was used. To
compare more than two sample groups, ANOVA followed by Bonferroni’s/
Dunnett’s post hoc tests or Kruskal-Wallis test followed by Dunn’s post hoc
test were used. Statistical analysis was carried out using OriginPro-8 (Origin-
Lab) and Prism (GraphPad) softwares.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Discussion, Supplemental
Experimental Procedures, and seven figures and can be found with this article
online at http://dx.doi.org/10.1016/j.celrep.2016.03.005.
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